Hepatotropism of GB virus C (GBV-C): GBV-C replication in human hepatocytes and cells of human hepatoma cell lines

Journal of Hepatology

Volumn 30, Issue 4, 1999, Pages 570-579

  Seipp, Stefanie ^a   Scheidel, Monika ^a   Hofmann, Walter J ^a   Töx, Ulrich ^a   Theilmann, Lorenz ^a   Goeser, Tobias ^a   Kallinowski, Birgit ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Fluorescence in situ hybridization; GBV C; Hepatotropism; HGV; In vitro infection; Minus strand RNA; Virus replication

Indexed keywords

ARTICLE; CELL STRAIN HEPG2; FLUORESCENCE IN SITU HYBRIDIZATION; GENE ISOLATION; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL; MARMOSET; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; VIRUS CHARACTERIZATION; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0033033537     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80186-X     Document Type: Article

References (53)

1. Deinhardt F., Holmes A.W., Capps R.B., Popper H. Studies on the transmission of human viral hepatitis to marmoset monkeys. J Exp Med. 125:1967;673-699.
2. Schlauder G.G., Dawson G.J., Simons J.N., Pilot-Matais T.J., Gutierrez R.A., Heynen C.A., et al. Molecular and serological analysis in the transmission of the GB hepatitis agents. J Med Virol. 46:1995;81-90.
3. Simons J.N., Pilot-Matais T.J., Leary T.P., Dawson G.J., Desai S.M., Schlauder G.G., et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci. 92:1995;3401-3405.
4. Leary T.P., Muerhoff A.S., Simons J.N., Pilot-Matias T.J., Erker J.C., Chalmers M.L., et al. Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E-hepatitis. J Med Virol. 48:1996;60-67.
5. Linnen J., Wages J. Jr., Zhang-Keck Z-Y, Fry K.E., Krawczynski K.Z., Alter H., et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 271:1996;505-508.
6. Alter H.J. The cloning and clinical implications of HGV and HGBV-C. N Engl J Med. 334:1996;1536-1537.
7. Zaidi Y., Chapman C.S., Myint S. Hepatitis G-associated aplastic anaemia. Lancet. 348:1996;471-472.
8. Bralet M.P., Roudot-Thoraval F., Pawlotsky J.M., Bastie A., Van Nhieu J.T., Duval J., et al. Histopathologic impact of GB virus C infection on chronic hepatitis C. Gastroenterology. 112:1997;188-192.
9. Pinho J.R.R., Capacci M.L., da Silva L.C., Carrilho F.J., Santos C.A., Pugliese V., et al. (GB virus C) in Brazil. Preliminary report. Rev Inst Med Trop S Paulo. 38:1996;243-246.
10. Wu R.R., Mizokami M., Cao K., Nakano T., Ge X.M., Wang S.S., et al. GB virus C/hepatitis G virus infection in Southern China. J Infect Dis. 175:1997;168-171.
11. Yoshiba M., Okamoto H., Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown etiology. Lancet. 346:1995;1131-1132.
12. Heringlake S., Osterkamp S., Trautwein C., Tillmann H.L., Böker K., Muerhoff S., et al. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet. 348:1996;1626-1629.
13. Kao J.H., Chen P.J., Chen D.S. GBV-C in the etiology of fulminant hepatitis. Lancet. 347:1996;120-121.
14. Kuroki T., Nishiguchi S., Tanaka M., Enomoto M., Kobayashi K. Does GBV-C cause fulminant hepatitis in Japan? Lancet. 347:1996;202.
15. Tanaka M., Nishiguchi S., Tanaka T., Enomoto M., Fukuda K., Takeda T., et al. Prevalence of GBV-C and hepatitis G virus variants in patients with fulminant hepatic failure in Japan. J Hepatol. 27:1997;966-972.
16. Moaven L.D., Locarnini S.A., Bowden D.S., Kim J.P., Breschkin A., McCaw R., et al. Hepatitis G virus and fulminant hepatic failure: evidence for transfusion-related infection. J Hepatol. 27:1997;613-619.
17. Muerhoff A.S., Leary T.P., Simons J.N., Pilot-Matias T.J., Dawson G.J., Erker J.C., et al. Genomic organization of GB viruses A and B: two new members of the flaviviridae associated with GB agent hepatitis. J Virol. 69:1995;5621-5630.
18. Laxton C.D., McMillan D., Sullivan V., Ackrill A.M. Expression and characterization of the hepatitis G virus helicase. J Viral Hepat. 5:1998;21-26.
19. Houghton M., Weiner A., Han J., Kuo G., Choo Q.L. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology. 14:1991;381-388.
20. Lamas E., Baccarini P., Housset C., Kremsdorf D., Brechot C. Detection of hepatitis C virus (HCV) RNA sequences in liver tissue by in situ hybridization. J Hepatol. 16:1992;219-223.
21. Müller H.M., Pfaff E., Goeser T., Kallinowski B., Solbach C., Theilmann L. Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication. J Gen Virol. 74:1993;669-676.
22. Nouri-Aria K.T., Sallie R., Sangar D., Alexander G.J., Smith H., Byrne J., et al. Detection of genomic and intermediate replicative strands of hepatitis C virus in liver tissue by in situ hybridization. J Clin Invest. 91:1993;2226-2234.
23. Yamada G., Nishimoto H., Endou H., Doi T., Takahashi M., Tsuji T., et al. Localization of hepatitis C viral RNA and capsid protein in the human liver. Dig Dis Sci. 38:1993;882-887.
24. Lanford R.E., Chavez D., Chisari F.V., Sureau C. Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR. J Virol. 69:1995;8079-8083.
25. Strand S., Hofmann W.J., Hug H., Müller M., Otto G., Strand D., et al. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - a mechanism of immune evasion? Nat Med. 12:1997;1361-1366.
26. Ikeda M., Sugiyama K., Mizutani T., Tanaka T., Tanaka K., Shimotohno K., et al. Hepatitis G virus replication in human cultured cells displaying susceptibility to hepatitis C virus infection. Biochem Biophys Res Commun. 235:1997;505-508.
27. Chomczynski P.N., Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Ann Biochem. 162:1987;156-159.
28. Seipp S., Wahl R., Mueller H.M., Stremmel W., Theilmann L., Goeser T. Sequence analysis of hepatitis GB virus C (GBV-C) isolates from 14 patients. Virus Res. 46:1996;81-88.
29. Lanford R.E., Sureau C., Jacob J.R., White R., Fuerst T.R. Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR. Virology. 202:1994;606-614.
30. Seipp S., Goeser T., Theilmann L., Kallinowski B. Establishment of a highly specific detection system for GB virus C (GBV-C) minus-strand RNA. Virus Res. 56:1998;183-189.
31. Seipp S., Müller HM Pfaff E., Stremmel W., Theilmann L., Goeser T. Establishment of persistent hepatitis C virus infection and replication in vitro. J Gen Virol. 78:1997;2467-2476.
32. Laskus T., Radowski M., Wang L.F., Vargas H., Rakela J. Detection of hepatitis G virus replication sites by using highly strand-specific rTth-based reverse transcriptase PCR. J Virol. 72:1998;3072-3075.
33. Pessoa M.G., Terrault N.A., Detmer J., Kolberg J., Collins M., Hassoba H.M., et al. Quantitation of hepatitis G and C viruses in the liver: evidence that hepatitis G virus is not hepatotropic. Hepatology. 27:1998;877-880.
34. Cantaloube J.F., Charrel R.N., Attoui H., Biagini P., De Micco P., De Lamballarie X. Evaluation of four PCR systems amplifying different genomic regions for molecular diagnosis of GB virus C infections. J Virol Meth. 64:1997;131-135.
35. Maggi F., Fornai C., Vatteroni M.L., Giorgi M., Antonietta M., Pistelle M., et al. Differences in hepatitis C virus quasispecies composition between liver, peripheral blood mononuclear cells and plasma. J Gen Virol. 78:1997;1521-1525.
36. Izraeli S., Pfleiderer C., Lion T. Detection of gene expression by PCR amplification of RNA derived from frozen heparinized whole blood. Nucl Acids Res. 19:1991;6051.
37. Rossen L., Norskov P., Holmstrom H., Rasmussen O.F. Inhibition of PCR by components of food samples, microbial diagnostic assays and DNA-extraction solutions. Int J Food Microbiol. 17:1992;37-45.
38. Laskus T., Radkowski M., Wang L.F., Vargas H., Rakela J. Lack of evidence for hepatitis G virus replication in the livers of patients co-infected with hepatitis C and G viruses. J Virol. 71:1997;7804-7806.
39. Seipp S., Wahl R., Seizer S., Müller H.M., Stemmel W., Theilmann L., et al. Prevalence of GB-C virus positive- and negative-strand RNA in human peripheral blood mononuclear cells of GBV-C infected and GBV-C/HCV co-infected patients. [abstract] Hepatology. 24:(Suppl):1996;288A.
40. Tribl B., Oesterreicher C., Pohanka E., Sunder-Plassmann G., Petermann D., Muller C. GBV-C/HGV in hemodialysis patients: anti-E2 antibodies and GBV-C/HGV RNA in serum and peripheral blood mononuclear cells. Kidney Int. 53:1998;212-216.
41. Blight K., Lesniewski R., LaBrooy J., Trowbridge R., Gowams E. Localization of hepatitis C virus proteins in infected liver tissue by immunofluorescence. Gastroenterol Jpn. 28:(Suppl5):1993;55-58.
42. Lau J.Y., Davis G.L. Detection of hepatitis C virus RNA genome in liver tissue by nonisotopic in situ hybridization. J Med Virol. 42:1994;268-271.
43. Lau G.K., Davis G.L., Wu S.P., Gish R.G., Balart L.A., Lau J.Y. Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: a study by in situ reversetranscription polymerase chain reaction. Hepatol. 23:1996;1318-1323.
44. Gastaldi M., Massacrier A., Planells R., Robaglia-Schlupp A., Portal-Bartolomei I., Bourliere M., et al. Detection by in situ hybridization of hepatitis C virus positive and negative RNA strands using digoxigenin-labeled cDNA probes in human liver cells. J Hepatol. 23:1995;509-518.
45. Shindo M., Di-Bisceglie A.M., Akatsuka T., Fong T.L., Scaglione L., Donets M., et al. The physical state of the negative strand of hepatitis C virus RNA in serum of patients with chronic hepatitis C. Proc Natl Acad Sci USA. 91:1994;8719-8723.
46. Gretch D.R., Bacchi C.E., Corey L., dela Rosa C., Lesniewski R., Kowdley K., et al. Persistent hepatitis C virus infection after liver transplantation: clinical and virological features. Hepatology. 22:1995;1-9.
47. Sansonno D., Cornacchiulo V., Racanelli V., Dammacco F. In situ simultaneous detection of hepatitis C virus RNA and hepatitis C virus-related antigens in hepatocellular carcinoma. Cancer. 80:1997;22-33.
48. Iacovacci S., Sargiacomo M., Parolini I., Ponzetto A., Peschle C., Carloni G. Replication and multiplication of hepatitis C virus genome in human fetal liver cells. Res Virol. 144:1993;275-279.
49. Ito T., Mukaigawa J., Zuo J., Hirabayashi Y., Mitamura K., Yasui K. Cultivation of hepatitis C virus in primary hepatocyte culture from patients with chronic hepatitis C results in release of high titer infectious virus. J Gen Virol. 77:1996;1043-1054.
50. Kato N., Ikeda M., Mizutani T., Sugiyama K., Noguchi M., Hirohashi S., et al. Replication of hepatitis C virus in cultured non-neoplastic human hepatocytes. Jpn J Cancer Res. 87:1996;787-792.
51. Shimizu Y.K., Iwamamoto A., Hijikata M., Purcell R.H., Yoshikura H. Evidence for in vitro replication of hepatitis C genome in a human T-cell line. Proc Natl Acad Sci USA. 89:1992;5477-5481.
52. Kato N., Ikeda M., Nakazawa T., Mizutani T., Shimotohno K. Susceptibility of human T-lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection. Biochem Biophys Res Commun. 206:1996;863-869.
53. Aiyama T., Yoshioka K., Hirofuji H., Kusakabe A., Yamada M., Tanaka K., et al. Changes in serum hepatitis C virus RNA titer and response to interferon therapy in patients with chronic hepatitis C. Dig Dis Sci. 39:1994;2244-2249.